Diazepam Ratiopharm (Diazepam)

Diazepam Ratiopharm is prescribed for several clinical conditions where its calming, anticonvulsant, or muscle‑relaxing effects are beneficial.

• Management of anxiety disorders and short‑term relief of anxiety symptoms.
• Adjunctive therapy for various seizure disorders, including status epilepticus.
• Relief of skeletal muscle spasm associated with acute musculoskeletal conditions.
• Treatment of alcohol withdrawal symptoms, including tremor and agitation.
• Sedation prior to diagnostic or therapeutic procedures when a short‑acting agent is desired.

Side‑effects of diazepam may vary in frequency and severity, ranging from mild, transient symptoms to rare but serious reactions.

Common

• Drowsiness or fatigue.
• Dizziness or light‑headed feeling.
• Impaired coordination or balance.
• Memory disturbances, especially short‑term.
• Slurred speech or visual changes.

Serious

• Severe allergic reaction such as rash, itching, swelling, or difficulty breathing.
• Respiratory depression, particularly when combined with other depressants.
• Marked confusion or delirium.
• Unusual mood changes, including depression or suicidal thoughts.
• Persistent weakness or loss of consciousness.

Healthcare providers consider several precautions before initiating diazepam therapy to minimize risks and ensure safe use.

• Pregnancy category D; use only if potential benefit justifies potential fetal risk.
• Potential for dependence, tolerance, and withdrawal with prolonged use; limit duration when possible.
• Caution in patients with hepatic impairment, as metabolism is primarily hepatic.
• Avoid abrupt discontinuation, especially after high‑dose or long‑term therapy.
• Use carefully in elderly patients due to increased sensitivity to sedative effects.
• Assess for a history of substance abuse or psychiatric disorders before prescribing.

Diazepam can interact with other medications, affecting its efficacy or increasing adverse effects.

Avoid

• Other central nervous system depressants (e.g., opioids, barbiturates, alcohol) due to additive respiratory depression.
• Strong CYP3A4 inhibitors (e.g., ketoconazole, itraconazole, clarithromycin) which can raise diazepam levels.
• Certain anticonvulsants like carbamazepine that may reduce diazepam concentrations.

Use with caution

• CNS stimulants or antidepressants that may alter sedation levels.
• Antifungal agents with moderate CYP3A4 inhibition (e.g., fluconazole).
• Herbal supplements such as St John’s wort that induce CYP enzymes.
• Medications affecting electrolyte balance, as they may influence muscle‑relaxant effects.
• Any drug that may potentiate central nervous system depression, requiring dose adjustments.